Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.

Asagi, Akinori

Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. [electronic resource] - Pancreas Jan 2013 - 11-9 p. digital

Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

1536-4828

10.1097/MPA.0b013e3182550d77 doi


Aged
Aged, 80 and over
Carcinoma, Pancreatic Ductal--diagnostic imaging
Diagnosis, Differential
Female
Fluorodeoxyglucose F18
Humans
Linear Models
Lymphatic Metastasis
Male
Middle Aged
Multimodal Imaging
Neoplasm Invasiveness
Neoplasm Recurrence, Local--diagnostic imaging
Neoplasm Staging
Pancreatic Neoplasms--diagnostic imaging
Positron-Emission Tomography
Predictive Value of Tests
Radiopharmaceuticals
Retrospective Studies
Tomography, X-Ray Computed
Treatment Outcome
Tumor Burden
Whole Body Imaging